文献速递妇科

选择性剪接特征的系统性分析揭示卵巢癌预后预测因子

Systematic profiling of alternative splicing signature reveals prognostic predictor for ovarian cancer.
PubMed 文献 · Gynecol Oncol · 2017-11-27

研究对TCGA中408例卵巢浆液性囊腺癌患者进行全基因组选择性剪接事件分析,在48,049个mRNA剪接事件中检出2,611个与总生存显著相关的选择性剪接事件,其中外显子跳跃事件预后预测能力最强,基于顶级显著剪接事件构建的预后预测模型在总生存2,000天时ROC曲线下面积为0.937。

要点

  • 在408例卵巢浆液性囊腺癌患者中分析全基因组选择性剪接事件。
  • 2,611个选择性剪接事件与总生存显著相关,外显子跳跃事件预后预测能力最强。
  • 基于顶级显著剪接事件构建的预后预测模型在总生存2,000天时AUC为0.937。

核心结论

  • 研究为卵巢浆液性囊腺癌患者构建了强有力的预后预测模型,并揭示了可能作为潜在机制的有意义的剪接网络。

研究设计与样本

  • 研究对TCGA中408例卵巢浆液性囊腺癌(OV)患者进行全基因组选择性剪接事件分析。
  • 研究整理七种类型的选择性剪接事件,并进行预后分析、构建预测模型和剪接网络。

主要发现

  • 在10,582个基因的48,049个mRNA剪接事件中,检出2,036个基因的2,611个选择性剪接事件与OV患者总生存显著相关。
  • 七种类型中选择性剪接事件中外显子跳跃事件是最强的预后因素。
  • 基于顶级显著选择性剪接事件构建的预后预测模型,在总生存2,000天时ROC曲线下面积为0.937,表明在区分患者结局方面具有强大效能。
  • 剪接相关网络提示剪接因子在OV中的作用呈现明显趋势。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The majority of genes are alternatively spliced and growing evidence suggests that alternative splicing is modified in cancer and is associated with cancer progression. Systematic analysis of alternative splicing signature in ovarian cancer is lacking and greatly needed. METHODS: We profiled genome-wide alternative splicing events in 408 ovarian serous cystadenocarcinoma (OV) patients in TCGA. Seven types of alternative splicing events were curated and prognostic analyses were performed with predictive models and splicing network built for OV patients. RESULTS: Among 48,049 mRNA splicing events in 10,582 genes, we detected 2,611 alternative splicing events in 2,036 genes which were significant associated with overall survival of OV patients. Exon skip events were the most powerful prognostic factors among the seven types. The area under the curve of the receiver-operator characteristic curve for prognostic predictor, which was built with top significant alternative splicing events, was 0.937 at 2,000 days of overall survival, indicating powerful efficiency in distinguishing patient outcome. Interestingly, splicing correlation network suggested obvious trends in the role of splicing factors in OV. CONCLUSIONS: In summary, we built powerful prognostic predictors for OV patients and uncovered interesting splicing networks which could be underlying mechanisms.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Zhu J, Chen Z, Yong L, et al. Systematic profiling of alternative splicing signature reveals prognostic predictor for ovarian cancer. Gynecol Oncol. 2017. PMID: 29191436. doi:10.1016/j.ygyno.2017.11.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。